glp-1 and alzheimer's disease the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential GLP-1 agonists linked to faster

, Rhodes, C

Pair with a protein shake to hit your morning protein target if needed

S.RiccioF.HoffmanD

doi: 10.1016/j.eclinm.2023.101865 15 YammineLde DiosCSuchtingRGreenCENielsenDAWalss-BassCet al

While some individuals may tolerate treatment without immediate complications, skipping laboratory testing can result in: Missed contraindications (e.g., thyroid abnormalities, pancreatitis risk) Undetected metabolic conditions (e.g., insulin resistance, liver disease) Poorly tailored dosing and monitoring There are limited scenarios where recent lab data (within 36 months) may suffice, but initiating treatment without any clinical baseline is generally considered incomplete care